STAA Staar Surgical Co

Price (delayed)

$33.31

Market cap

$1.63B

P/E Ratio

75.7

Dividend/share

N/A

EPS

$0.44

Enterprise value

$1.48B

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are ...

Highlights
STAA's P/E is 62% below its 5-year quarterly average of 196.9 and 15% below its last 4 quarters average of 88.9
Staar Surgical's equity has increased by 15% YoY
Staar Surgical's EPS has decreased by 47% YoY but it has increased by 2.3% QoQ
Staar Surgical's net income has decreased by 46% YoY but it has increased by 4.9% from the previous quarter
Staar Surgical's debt has increased by 15% YoY
STAA's quick ratio is down by 8% YoY and by 8% QoQ

Key stats

What are the main financial stats of STAA
Market
Shares outstanding
48.87M
Market cap
$1.63B
Enterprise value
$1.48B
Valuations
Price to book (P/B)
4.21
Price to sales (P/S)
5.01
EV/EBIT
55.43
EV/EBITDA
46.51
EV/Sales
4.59
Earnings
Revenue
$322.42M
EBIT
$26.71M
EBITDA
$31.83M
Free cash flow
-$3.59M
Per share
EPS
$0.44
Free cash flow per share
-$0.07
Book value per share
$7.91
Revenue per share
$6.64
TBVPS
$10.03
Balance sheet
Total assets
$488.69M
Total liabilities
$102.74M
Debt
$35.83M
Equity
$385.95M
Working capital
$300.23M
Liquidity
Debt to equity
0.09
Current ratio
5.62
Quick ratio
4.85
Net debt/EBITDA
-4.62
Margins
EBITDA margin
9.9%
Gross margin
78.4%
Net margin
6.6%
Operating margin
8.7%
Efficiency
Return on assets
4.7%
Return on equity
5.9%
Return on invested capital
8.7%
Return on capital employed
6.3%
Return on sales
8.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
6.63%
1 week
8.61%
1 month
16.06%
1 year
-41.24%
YTD
6.73%
QTD
6.73%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$322.42M
Gross profit
$252.65M
Operating income
$28.1M
Net income
$21.35M
Gross margin
78.4%
Net margin
6.6%
Staar Surgical's net margin has plunged by 53% YoY
STAA's operating income has surged by 51% since the previous quarter but it is down by 36% year-on-year
Staar Surgical's net income has decreased by 46% YoY but it has increased by 4.9% from the previous quarter
Staar Surgical's operating margin has increased by 45% from the previous quarter but it has decreased by 44% YoY

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
P/E
75.7
P/B
4.21
P/S
5.01
EV/EBIT
55.43
EV/EBITDA
46.51
EV/Sales
4.59
STAA's P/E is 62% below its 5-year quarterly average of 196.9 and 15% below its last 4 quarters average of 88.9
Staar Surgical's EPS has decreased by 47% YoY but it has increased by 2.3% QoQ
STAA's price to book (P/B) is 67% lower than its 5-year quarterly average of 12.8 and 33% lower than its last 4 quarters average of 6.3
Staar Surgical's equity has increased by 15% YoY
The stock's price to sales (P/S) is 66% less than its 5-year quarterly average of 14.6 and 32% less than its last 4 quarters average of 7.4
The revenue has grown by 13% YoY and by 3.9% from the previous quarter

Efficiency

How efficient is Staar Surgical business performance
The ROIC has plunged by 57% YoY but it has increased by 28% from the previous quarter
Staar Surgical's return on assets has shrunk by 54% YoY
The ROE has plunged by 54% YoY
Staar Surgical's return on sales has decreased by 45% YoY but it has increased by 19% QoQ

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 24% YoY and by 11% from the previous quarter
The total assets is up by 17% year-on-year and by 3.6% since the previous quarter
Staar Surgical's debt is 91% less than its equity
Staar Surgical's equity has increased by 15% YoY
Staar Surgical's debt has increased by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.